乳腺癌转移的转化适应和新兴的治疗机会
Siyu Chen1, Albertas Navickas2, Hani Goodarzi1
1Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA; Department of Urology, University of California, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA.
Trends in pharmacological sciences
|March 7, 2024
概括
乳腺癌细胞适应它们的翻译过程以生存和扩散. 了解这种转化适应可以为治疗转移性乳腺癌提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 乳腺癌转移是癌症相关死亡的主要原因.
- 瘤微环境 (TME) 对癌细胞生存提出了挑战.
- 越来越多地认识到转化适应对TME中癌细胞存活至关重要.
研究的目的:
- 系统地审查乳腺癌细胞如何使用转化适应来驱动转移.
- 要突出翻译机器,mRNA特征和非编码RNA的调控作用.
- 讨论这些发现对乳腺癌治疗的治疗影响.
主要方法:
- 对现有文献进行系统审查.
- 对乳腺癌转移的调节机制的分析.
- 综合当前的发现和新兴的概念在翻译控制.
主要成果:
- 乳腺癌细胞使用特定的翻译机制来适应.
- mRNA序列,结构和相关的RNA (tRNA,跨作用RNA) 是关键的调节者.
- 转化适应是TME内的癌细胞存活和转移的组成部分.
结论:
- 转化适应是使乳腺癌转移成为可能的关键机制.
- 向转化调节为新型乳腺癌疗法提供了一个有希望的途径.
- 对这些复杂机制的进一步研究可以导致改善治疗策略.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


